Enter your login e-mail to the account
Search
Search parameters
Search results
- Lung cancer has crossed the threshold into the third millennium – part 1
MUDr. Anton Dzian, MUDr. Elena Kavcová, PhD., MUDr. Martina Ondrušová
(5/2010, Review articles ) - ROLE OF GENERAL PRACTIONER IN THE TOTAL MANAGEMENT OF LUNG CANCER
doc. MUDr. Peter Beržinec, CSc.
(7-8/2007, Topic ) - Rapid diagnostics of lung cancer – what is the role of a general practitioner?
doc. MUDr. Peter Beržinec, CSc.
(5/2014, Review articles )
- Neurologické projevy systémových maligních nádorů
MUDr. Igor Nestrašil
(1/2005, Main topic ) - What was hiding behind a migraine attack?
MUDr. Anna Šefčíková, MUDr. Miloslav Dvorák, PhD.
(2/2017, Case reports ) - Radiotherapy in brain metastases treatment
prof. MUDr. Pavel Šlampa, CSc., doc. MUDr. Radim Jančálek, Ph.D., MUDr. Ludmila Hynková
(5/2016, Main topic ) - Radioterapie a chemoterapie zhoubných nádorů centrálního nervového systému
MUDr. Pavel Vodvářka, Ph.D.
(5/2003, Main topic ) - Paraneoplastic neurological syndromes – essential characteristics, classification, etiopathogenesis and diagnostics
doc. MUDr. Pavel Štourač, Ph.D., prof. MUDr. Zdeněk Ambler, DrSc.2
(1/2013, Main topic ) - Paraneoplastic neurological syndromes of central nervous system
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D.
(1/2013, Main topic ) - Paraneoplastic syndromes of peripheral nerves, neuromuscular junction and muscles
prof. MUDr. Zdeněk Ambler, DrSc.
(1/2013, Main topic ) - Lambert-Eaton myasthenic syndrome in a child
MUDr. Jan Staněk, MUDr. František Vlček
(3/2012, Case reports )
- Neuroendocrine prostate cancer with primary origin in the lungs
MUDr. Tomaš Chmelensky, MUDr. Pavel Hanek, MUDr. Karel Franěk, MUDr. Josef Rejlek, MUDr. Jiři Zvěřina
(2/2016, Communication from practice )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - What’s new in immunotherapy for non-small cell lung cancer?
MUDr. Zuzana Pribulová
(1/2021, Main topic ) - Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - Zaujímavosti zo zahraničnej literatúry - Preventívna kraniálna iradiácia verzus sledovanie pri radikálne liečenom štádiu III nemalobunkového karcinómu pľúc: randomizovaná štúdia fázy III INVALT-11/DLCRG-02
doc. MUDr. Peter Beržinec, CSc.
(5/2018, Information & comments ) - Stereotactic radiotherapy in the treatment of non-small cell lung cancer
doc. MUDr. Pavol Dubinský, PhD., MHA, MUDr. Iveta Priatelová, Ing. Miroslav Olejár
(1/2021, Main topic ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - 12th Central European Lung Cancer Conference
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Events ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Profile of atezolizumab in the treatment of lung cancer
MUDr. Zuzana Pribulová
(2/2024, Drugs & drug classes ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Pembrolizumab versus Chemotherapy for PD-L1–Positive Non-Small-Cell Lung Cancer
doc. MUDr. Peter Beržinec, CSc.
(5/2016, Information & comments ) - DNA repair and its reference to resistance to anticancer therapy
doc. MUDr. Mária Wagnerová, CSc., MUDr. Martina Čižmáriková, PhD., prof. MUDr. Anton Kohút, DrSc.,, prof. MUDr. Ladislav Mirossay, DrSc.
(4/2007, Review articles ) - Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial
doc. MUDr. Peter Beržinec, CSc.
(3/2006, Information & comments ) - Role of thoracoscopyin the diagnosis and treatment of lung cancer
doc. MUDr. Julián Hamžík, PhD., MUDr. Anton Dzian
(4/2007, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Surgical treatment of lung cancer
doc. MUDr. Roman Benej, PhD., prof. MUDr. Svetozár Haruštiak, CSc., MUDr. Miroslav Janík, MUDr. Tibor Krajč, MUDr. František Žernovický
(4/2007, Review articles ) - Optimal timing of chemotherapy and radiotherapy for stage III non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc., h. doc. MUDr. Elena Bolješíková, CSc.
(4/2007, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Managed hypertensive crisis induced by bevacizumab in patient with metastatic lung adenocarcinoma
MUDr. Klaudia Grácová, MUDr. Lucia Doláková
(6/2015, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - New methods of nutritional support in cancer cachexia
prof. MUDr. Zdeněk Zadák, CSc., MUDr. Radomír Hyšpler, Ph.D., RNDr. Alena Tichá, Ph.D., MUDr. Robert Hromádka
(2/2010, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2010, Information & comments ) - Importance of immunohistochemistry and application of TTF-1 and napsin A in differential diagnosis of primary pulmonary adenocarcinomas and pulmonary metastases of extrapulmonary origins
MUDr. Adela Mikuľaková, MUDr. Zuzana Hríbiková
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Publikujeme v zahraničí
(2/2017, Information & comments ) - Treatment of pulmonary neuroendocrine tumors
MUDr. Milan Krošlák
(5/2017, Main topic ) - Cancer cachexia in the perspective of the new definition
MUDr. Andrea Škripeková
(2/2012, Review articles ) - Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer
doc. MUDr. Peter Beržinec, CSc.
(6/2015, Information & comments ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - Publikujeme v zahraničí
(3/2011, Information & comments ) - Zaujímavosti z literatúry: Analýzy biomarkerov a definitívne výsledky celkového prežitia z randomizovanej, otvorenej, prvolíniovej štúdie gefitinib verzus karboplatina/paklitaxel u klinicky vybraných pacientov s pokročilým nemalobunkovým karcinómom pľúc v
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(3/2011, Information & comments ) - Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
Doc. MUDr. Peter Beržinec, CSc.
(5/2017, Information & comments ) - Neuroendocrine tumors: biopsy (pathological) classification and its clinical significance
prof. MUDr. Lukáš Plank, CSc., doc. MUDr. Karol Kajo, PhD., MUDr. Katarína Macháleková, PhD.
(4/2011, Review articles ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - The characteristics of lung cancer in young adults
MUDr. Peter Kasan, MUDr. Mária Černá, CSc., MUDr. Radka Cahajlová, MUDr. Marián Marták, MUDr. Milada Veselá, MUDr. Lucia Denková, MUDr. Zuzana Šviheľová-Lišková
(3/2016, Original articles & case reports ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Data back Merck’s Keytruda for first-line NSCLC
doc. MUDr. Peter Beržinec, CSc.
(3/2016, Information & comments ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - The effectiveness of second-generation ALK-TKIs in advance non-small cell lung cancer
MUDr. Simona Laštíková, MUDr. Michal Urda, PhD., MUDr. Juraj Mazal, MUDr. Marek Lafférs
(6/2021, Case reports ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - The turbulent evolution of treatment strategies for early-diagnosed NSCLC
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(S2/2023, Review articles ) - Treatment of non-small-cell lung cancer in elderly patients
Doc. MUDr. Peter Beržinec, CSc.
(3/2017, Main topic ) - First guidelines for oligometastatic non-small cell lung cancer and radiotherapy
MUDr. Karol Martinka
(S2/2023, Review articles ) - News in the treatment of non-small cell lung cancer in the first half of 2023 in the world and new therapies in Slovakia
MUDr. Dominik Šafčák, PhD., MPH
(S2/2023, Review articles ) - Consensus of the multidisciplinary working group on organisational changes in the care of patients with early diagnosed non-small cell lung cancer
MUDr. Milada Veselá, MUDr. Lucia Denková, Doc. MUDr. Anton Dzian, PhD., MUDr. Roman Klimčík, MUDr. Jana Jankurová, MUDr. Peter Juhos, PhD., MUDr. Gabriela Chowaniecová, PhD., MUDr. Štefan Laššán, PhD., MPH, MUDr. Peter Palúch, MUDr. Zuzana Pribulová, MUDr. Michal Urda, PhD.
(S2/2023, Review articles ) - Current possibilities of immunotherapy in non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(3/2020, Review articles ) - Why do some lung cancer patients receive no anticancer treatment?
doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Increased production of HE4 by tumour tissues and its importance of measurement in patients with malignant tumours
MUDr. Jaroslav Weissensteiner, doc. Mgr. Eva Babušíková, PhD.
(1/2015, Review articles ) - Zaujímavosti zo zahraničnej literatúry
Doc. MUDr. Peter Beržinec, CSc.
(2/2018, Information & comments ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Pemetrexed - antifolate cytostatic drug for treatment of malignant pleural mesothelioma and non-small cell lung cancer
doc. PharmDr. Juraj Sýkora, CSc.
(4/2009, Drugs & drug classes ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Information & comments ) - A new trend in targeted (biologic) therapy of non-small cell lung cancer in the 2009 – maintenance therapy
MUDr. Peter Kasan
(1/2010, Review articles ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - The role of radiotherapy in lung cancer
MUDr. Elena Bolješíková, CSc.
(1/2010, Review articles ) - Lipegfilgrastim − new drug form similar to filgrastim in treatment of neutropenia of oncologic patients
prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(4/2015, Drugs & drug classes ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Publikujeme v zahraničí
(4/2015, Information & comments ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - 11 11TH TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Events ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - RNDr. Gabriel Minárik, PhD.
RNDr. Gabriel Minárik, PhD.
(5/2014, Main topic ) - Radiotherapy of bone metastases
doc. MUDr. Pavol Dubinský, PhD.
(5/2013, Main topic ) - Stereotactic radiotherapy lung cancer
MUDr. Iveta Priatelová, MUDr. Natália Janíčková, MUDr. Marek Marinčák
(5/2013, Main topic ) - Translačný výskum v onkológii – prvé skúsenosti Jednotky translačného výskumu
doc. MUDr. Jozef Mardiak, CSc., doc. MUDr. Michal Mego, PhD., RNDr. Daniela Svetlovská, PhD.
(5/2014, Review articles ) - Treatment of inicially metastatic small-cell lung cancer
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, doc. MUDr. Mária Tamášová, CSc.
(5/2013, Review articles ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Information & comments ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Radiotherapy of inoperable, locally advanced non-small cell lung cancer
MUDr. Iveta Priatelová, Ing. Miroslav Olejár
(2/2023, Main topic ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Advances in the systemic treatment of non-small cell lung cancer
MUDr. Mária Černá, CSc.
(2/2023, Main topic ) - Surgery for non-small cell lung cancer – current trends
Doc. MUDr. Anton Dzian, PhD., MUDr. Marek Malík, PhD.
(2/2023, Main topic ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - ANTIBACTERIAL PROPHYLAXIS IN NEUTROPENIC CANCER PATIENTS
h. doc. MUDr. Ľuboš Drgoňa
(5/2007, Review articles ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - GROWTH FACTORS IN ONCOLOGY (part 1)
prof. MUDr. Elena Tóthová, CSc.
(5/2007, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - 12 12TH TH WORLD CONFERENCE ON LUNG CANCER, WORLD CONFERENCE ON LUNG CANCER,
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Events ) - Prophylactic cranial irradiation in extensive small-cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Information & comments ) - PET/CT using 18-fluorodihydroxyphenylalanine in neuroendocrine tumours according to their types
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová
(1/2016, Review articles ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Glutamine in oncological treatment
MUDr. Zuzana Dolinská
(1/2024, Review articles ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(6/2010, Review articles ) - Hereditary oncological syndromes: DNA mutations and diagnostic techniques of genetic testing
RNDr. Michal Konečný, PhD., RNDr. Katarína Závodná, PhD., Mgr. Ján Markus, PhD., Mgr. Lenka Dolešová, prof. RNDr. Vanda Repiská, PhD., doc. MUDr.aniel Böhmer, PhD.1
(2/2015, Main topic ) - Pembrolizumab for the treatment of non-small-cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(2/2015, Information & comments ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Zaujímavosti z literatúry - Stratégie pre predĺženú liečbu u pacientov s pokročilým nemalobunkovým karcinómom pľúc
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Information & comments ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - The use of 18F-FDG PET/CT for radiotherapy planning
MUDr. Andrea Masaryková
(2/2016, Main topic ) - IMMUNOHISTOCHEMICAL ANALYSIS OF KOMPLEX DIAGNOSTIC OF MALIGNANT LUNG TUMOURS
doc. MUDr. František Ondriaš, CSc., MUDr. Jana Rampalová, MUDr. Petya Marinova, Bc. Silvia Orthová, MUDr. Andrea Jašková, Mgr. Zuzana Gubrij
(4/2008, Review articles ) - Stereotactic body radiotherapy
doc. MUDr. Pavol Dubinský, PhD., MUDr. Martin Jasenčák
(2/2016, Main topic ) - Chemotherapy for malignant pleural mesothelioma
doc. MUDr. Peter Beržinec, CSc.
(6/2011, Review articles ) - SHOX2 gene methylation as a diagnostic marker of lung cancer
RNDr. Michal Konečný, PhD., Mgr. Lenka Dolešová, doc. RNDr. Iveta Waczulíková, PhD., doc. MUDr. Ivan Majer, CSc., Mgr. Ján Markus, PhD.1, MUDr. Helena Novosadová
(2/2016, Original articles & case reports ) - Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Information & comments ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - Publikujeme v zahraničí
(2/2016, Information & comments ) - CURRENT TRENDS OF THE EXTERNAL RADIOTHERAPY IN TREATMENT OF NON SMALL-CELL LUNG CANCER
MUDr. Richard Hrubý, PhD.
(3/2006, Review articles ) - News in the treatment of lung tumors in the elderly
MUDr. Zuzana Pribulová
(6/2023, Main topic ) - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(6/2011, Information & comments )
- HOME OXYGEN THERAPY – DIFFERENT DISEASES, DIFFERENT INDICATIONS, DIFFERENT AIMS
doc. MUDr. Peter Beržinec, CSc.
(4/2008, Review articles )
- Brain metastases in solid tumours
doc. MUDr. Peter Beržinec, CSc.
(1/2012, Review articles )
- Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(3/2011, Review articles )
- Limits of surgical treatment of lung cancer in elderly
MUDr. Milan Stebnický, PhD., MUDr. Róbert Šimon, PhD., MPH, MUDr. Marián Kudláč, doc. MUDr. Jozef Belák, PhD.
(2/2014, Review articles ) - Stem cells in surgery
MUDr. Martina Fialová, MUDr. Ivan Brychta, PhD.
(2/2012, Review articles )